ConductScience.org, home

Paper20826257

Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.

Cadeddu C and 7 others. Am Heart J, 2010. Cited by 108 papers, by iCite.

Cite this record

ConductScience Library. Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. Papers, record 20826257. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20826257

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
PubMed
Journal
Am Heart J
PubMed
Year
2010
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
108
iCite
Relative citation ratio, by iCite
2.82
iCite
Revised in PubMed
2024-12-17
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cadeddu CChristian
2Piras AAlessandra
3Mantovani GGiovanni
4Deidda MMartino
5Dessì MMariele
6Madeddu CClelia
7Massa EElena
8Mercuro GGiuseppe

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin II Type 1 Receptor BlockersMajor topic
BenzimidazolesMajor topic
BenzoatesMajor topic
HeartMajor topic
Oxidative StressMajor topic
Adult
Aged
Antibiotics, Antineoplastic
Cytokines
Echocardiography, Doppler
Epirubicin
Female
Humans
Inflammation
Inflammation Mediators
Male
Middle Aged
Myocardial Contraction
Renin-Angiotensin System
Systole
Telmisartan
Ventricular Dysfunction, Left

Source PubMed

Download CSV of topics

Cited by63

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.

PMIDTitleJournalYearIn PapersSource
41595575A Narrative Review on Nitrate-Rich Diets as Adjuncts to Antihypertensive Therapy: Enhancing Treatment Efficacy via Oxidative Stress Modulation.Biomedicines2025https://conductscience.org/library/papers/41595575PubMed
41210341Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches.Front Cardiovasc Med2025https://conductscience.org/library/papers/41210341PubMed
41068418Effects of renin-angiotensin system inhibitors in cancer patients: a systematic review and meta-analysis of randomized controlled trials.Hypertens Res2025https://conductscience.org/library/papers/41068418PubMed
40890873
SGLT2i Dapagliflozin in primary prevention of chemotherapy induced cardiotoxicity in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy +/- trastuzumab: rationale and design of the multicenter PROTECT trial.
Cardiooncology2025https://conductscience.org/library/papers/40890873PubMed
40141815Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment.Life (Basel)2025https://conductscience.org/library/papers/40141815PubMed
39505307Cardiovascular Autonomic Dysfunction Before and After Chemotherapy in Cancer Patients.J Clin Neurol2024https://conductscience.org/library/papers/39505307PubMed
39377963Inflammation in Chemotherapy-Induced Cardiotoxicity.Curr Cardiol Rep2024https://conductscience.org/library/papers/39377963PubMed
39249555Cardioprotection strategies for anthracycline cardiotoxicity.Basic Res Cardiol2025https://conductscience.org/library/papers/39249555PubMed
38348396Natural products for the treatment of chemotherapy-related cognitive impairment and prospects of nose-to-brain drug delivery.Front Pharmacol2024https://conductscience.org/library/papers/38348396PubMed
37938165Shenmai injection ameliorates doxorubicin-induced myocardial injury by suppressing autophagy-apoptosis via miR-30a.Aging (Albany NY)2023https://conductscience.org/library/papers/37938165PubMed
37314568Comparing Renin-Angiotensin-Aldosterone Blockade Regimens for Long-Term Chemotherapy-Related Cardiac Dysfunction: A Network Meta-Analysis.Cardiovasc Drugs Ther2025https://conductscience.org/library/papers/37314568PubMed
37257007Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity.Anatol J Cardiol2023https://conductscience.org/library/papers/37257007PubMed
36672461Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis.Cancers (Basel)2023https://conductscience.org/library/papers/36672461PubMed
36015155Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36015155PubMed
35528842Novel Therapeutics for Anthracycline Induced Cardiotoxicity.Front Cardiovasc Med2022https://conductscience.org/library/papers/35528842PubMed
35497981Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.Front Cardiovasc Med2022https://conductscience.org/library/papers/35497981PubMed
34579775Rationale and design of the PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial: a randomized, placebo-controlled, multicenter trial.Cardiooncology2021https://conductscience.org/library/papers/34579775PubMed
34368589Bioactivity Studies of Hesperidin and XAV939.ACS Omega2021https://conductscience.org/library/papers/34368589PubMed
34356349Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review.Antioxidants (Basel)2021https://conductscience.org/library/papers/34356349PubMed
33955207Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.ESC Heart Fail2021https://conductscience.org/library/papers/33955207PubMed

See all 63 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGTR1185PubTator's text mininghttps://conductscience.org/library/genes/185NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20826257

GET https://conductscience.org/api/papers/v1/20826257/cited_by?page=2